The changes of cortical metabolism associated with the clinical response to Donepezil therapy in traumatic brain injury

Clinical Neuropharmacology

Volumn 32, Issue 2, 2009, Pages 63-68

  Kim, Yong Wook ^a   Kim, Deog Young ^a   Shin, Ji Cheol ^a   Park, Chang Il ^a   Lee, Jong Doo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cerebral neural network; Cognitive impairment; Cortical metabolism; Donepezil; Traumatic brain injury

Indexed keywords

DONEPEZIL; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; ATTENTION; BOSTON NAMING TEST; BRAIN CORTEX; BRAIN METABOLISM; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COLORED PROGRESSIVE MATRICES; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRONTAL CORTEX; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL CORTEX; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; WECHSLER MEMORY TEST;

ADULT; BRAIN INJURIES; CEREBRAL CORTEX; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INDANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY;

EID: 67749139884     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31816f1bc1     Document Type: Article

References (37)

1. Masanic CA, Bayley MT, VanReekum R, et al. Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil 2001;82:896-901.
2. Arciniegas D, Adler L, Topkoff J, et al. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj 1999;13:1-13.
3. Povlishock JT, Katz DI. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil 2005;20:76-94.
4. Arciniegas DB. The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Curr Psychiatry Rep 2003;5:391-399.
5. Phillips JP, Devier DJ, Feeney DM. Rehabilitation pharmacology: bridging laboratory work to clinical application. J Head Trauma Rehabil 2003;18:342-356.
6. Arciniegas DB, Silver JM. Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol 2006;17:25-42.
7. Whitlock JA Jr. Brain injury, cognitive impairment, and donepezil. J Head Trauma Rehabil 1999;14:424-427.
8. Khateb A, Ammann J, Annoni JM, et al. Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol 2005;54:39-45.
9. Morey CE, Cilo M, Berry J, et al. The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study. Brain Inj 2003;17:809-815.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Prigatano GP. Wechsler Memory Scale: a selective review of the literature. J Clin Psychol 1978;34:816-832.
12. Jordan FM, Ozanne AE, Murdoch BE. Performance of closed head-injured children on a naming task. Brain Inj 1990;4:27-32.
13. Villardita C. Raven's colored progressive matrices and intellectual impairment in patients with focal brain damage. Cortex 1985;21:627-634.
14. Talairach J, Tournoux P. Co-Planar Sterotaxic Atlas of the Human Brain. Thieme: New York, 1988.
15. Dixon CE, Liu SJ, Jenkins LW, et al. Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat. Behav Brain Res 1995;70:125-131.
16. Taverni JP, Seliger G, Lichtman SW. Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Inj 1998;12:77-80.
17. Walker W, Seel R, Gibellato M, et al. The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes. Brain Inj 2004;18:739-750.
18. Zhang L, Plotkin RC, Wang G, et al. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004;85:1050-1055.
19. Nakayama N, Okumura A, Shinoda J, et al. Relationship between regional cerebral metabolism and consciousness disturbance in traumatic diffuse brain injury without large focal lesions: an FDG-PET study with statistical parametric mapping analysis. J Neurol Neurosurg Psychiatr 2006;77:856-862.
20. Shiga T, Ikoma K, Katoh C, et al. Loss of neuronal integrity: a cause of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage. Eur J Nucl Med Mol Imaging 2006;33:817-822.
21. Alavi A. Functional and anatomic studies of head injury. J Neuropsychiatry Clin Neurosci 1989;1:50.
22. Newberg AB, Alavi A. Neuroimaging in patients with head injury. Seminars in Nuclear Medicine 2003;33:136-147.
23. Saykin AJ, Wishart HA, Rabin LA, et al. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 2004;127:1574-1583.
24. Teipel SJ, Drzezga A, Bartenstein P, et al. Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial. Psychopharmacology 2006;187:86-94.
25. Deco G, Rolls ET. Attention, short-term memory, and action selection: a unifying theory. Prog Neurobiol 2005;76:236-256.
26. Knudsen EI. Fundamental components of attention. Annu Rev Neurosci 2007;30:57-78.
27. Itti L, Koch C. Computational modelling of visual attention. Nat Rev Neurosci 2001;2:194-203.
28. Gitelman DR, Nobre AC, Parrish TB, et al. A large-scale distributed network for covert spatial attention: further anatomical delineation based on stringent behavioural and cognitive controls. Brain 1999;122(Pt 6): 1093-1106.
29. Ceravolo R, Volterrani D, Tognoni G, et al. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease. Clin Neuropharmacol 2004;27:166-170.
30. Furey ML, Pietrini P, Haxby JV. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 2000;290:2315-2319.
31. Kircher TT, Erb M, Grodd W, et al. Cortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: preliminary findings from a pharmaco-fMRI study. Am J Geriatr Psychiatr 2005;13:1006-1013.
32. Murphy PC, Sillito AM. Cholinergic enhancement of direction selectivity in the visual cortex of the cat. Neuroscience 1991;40:13-20.
33. Saenz M, Buracas GT, Boynton GM. Global effects of feature-based attention in human visual cortex. Nat Neurosci 2002;5:631-632.
34. Humphreys GW, Price CJ, Riddoch MJ. From objects to names: a cognitive neuroscience approach. Psycholl Res 1999;62:118-130.
35. Price CJ, Moore CJ, Humphreys GW, et al. The neural regions sustaining object recognition and naming. Proc R Soc B Biol Sci 1996;263: 1501-1507.
36. Köhler S, McIntosh AR, Moscovitch M, et al. Functional interactions between the medial temporal lobes and posterior neocortex related to episodic memory retrieval. Cereb Cortex 1998; 8:451-461.
37. Goekoop R, Scheltens P, Barkhof F, et al. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation - a pharmacological fMRI study. Brain 2006;129:141-157.